抗逆转录病毒药物的研发-人类免疫缺陷病毒-Clinical Care Options Chinese

2020 年当代的艾滋病毒管理了解更多

我对2020年第23届国际艾滋病大会（线上）中3篇抗病毒治疗（ART）报告的看法了解更多

第23届国际艾滋病大会（在线) 了解更多

我为什么对长效抗逆转录病毒疗法感到兴奋，我为什么认为它会保留下来！了解更多

2020 年逆转录病毒和机会性感染会议了解更多

CCO.Feature.Widgets.InPractice.Tagline

HIVCCO.Feature.Widgets.InPractice.LatestNewsTitle

New data from HPTN 083 demonstrate long-acting cabotegravir injections administered every 8 weeks highly effective in preventing HIV infection in at-risk men who have sex with men and transgender women

Updated DHHS and EACS recommendations for first-line antiretroviral therapy

Updated guidelines on the use of dolutegravir in women of childbearing potential

Addition of dolutegravir/lamivudine as a DHHS-recommended first-line ART regimen for most patients with HIV

CCO.Feature.Widgets.InPractice.MoreLinkTitle